AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

The Environmental Impact of Biologic Therapy

Description

The presentation discusses the environmental impact of biologic therapies, particularly focusing on packaging and transport issues. Biologics, which are protein-based treatments requiring strict temperature controls during shipment, pose unique challenges compared to conventional drugs. A significant concern arises during the "last mile" of delivery when boxes may be exposed to non-ideal conditions, risking temperature stability. Current packaging, typically involving Styrofoam and non-recyclable ice packs, is not sustainable and contributes to significant plastic waste and CO2 emissions. The biologic market is growing rapidly, predicted to reach $600 billion by 2030, further exacerbating the environmental concerns associated with their delivery. Despite the widespread need for these complex therapies, current regulations often limit the shipment frequency, resulting in more packaging waste. The speaker emphasizes the necessity for awareness, improved measurement of the environmental impact, and the development of sustainable packaging solutions, urging collaboration among healthcare providers, pharmacies, and payers to implement better practices, as demonstrated by companies like Optum RX, which use biodegradable packing materials. The call to action is to incentivize change towards environmentally friendly strategies in biologic therapy logistics.

View more

Conclusions

  • Biologics have revolutionized treatment for dermatological diseases, but their packaging significantly impacts the environment.
  • The 'last mile' of biologic distribution poses the greatest risk for temperature stability and environmental concerns.
  • Conventional packaging for biologics, primarily made from Styrofoam, is not recyclable and contributes to plastic pollution.
  • The estimated annual usage of Styrofoam for biologics leads to substantial CO2 emissions and water pollution.
  • The market for biologics continues to grow rapidly, increasing the environmental burden due to hazardous packaging.
  • Current pharmaceutical policies often require monthly dispensing, exacerbating waste and environmental challenges.
  • Raising awareness and improving measurement of the environmental impact of biologic therapies is crucial.
  • Collaboration with industry and healthcare payers is needed to promote sustainability in biologic packaging.
  • Examples of sustainable packaging exist, such as Optum Rx's use of biodegradable materials, which could set a precedent for the industry.
  • Urgent action is required to encourage pharmacies to adopt eco-friendly packaging solutions.
  • Camacho et al. Cancer Med. 2014 Aug;3(4):889-99.
  • S S Yang et al 2018 IOP Conf. Ser .: Earth Environ. Sci. 150 012005
  • Thaysen, Clara, et al. Frontiers in Marine Science 5 (2018): 71.
  • Capricho JC et al. 2022 Nov 18;14(22):5010.
  • Lexchin J. Affordable Biologics for All. JAMA Netw Open. 2020;3(4):e204753.